DMAC vs HAS · $157.4M cap vs P/E 25, rev $4.75B
DiaMedica Therapeutics Inc (DMAC) versus Hasbro Inc (HAS) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Hasbro Inc (HAS) is a leisure company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
DMAC currently screens at market cap $157.4M. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Not investment advice. Open the DMAC and HAS stock pages for the full models.
Not investment advice.